PEACH Trial: Prescribed Exercise After Chemotherapy (PEACH)
Individually Prescribed Exercise Versus Usual Care in a Heterogeneous Cancer Survivor Population: A Pragmatic Randomized Controlled Trial
Many cancer survivors suffer symptoms such as fatigue and dyspnea which may persist for years or months after their chemotherapy has finished. Despite the known benefits of exercise and its potential to address many of the symptoms after cancer, the type of practical exercise programme which best suits this population is not known.
Many exercise programmes performed in cancer survivors take place over many weeks or months and include people with specific types of cancer. Such programmes may therefore not be suitable for the majority of cancer survivors and would pose serious practical difficulties with high drop-out rates and expensive resource consumption if they were extended into clinical practice.
We propose to run an 8-week exercise intervention in a mixed cancer population.
Hypothesis: A brief, individually tailored 8-week intervention will increase fitness and improve other physical symptoms in a mixed cancer survivor population after chemotherapy.
調査の概要
詳細な説明
Background: Many cancer survivors suffer a range of physical and psychological symptoms with may persist for years or months after treatment finishes. Despite the known benefits of exercise and its potential to address many of these adverse effects of treatment, the role of exercise as well as its optimum duration, frequency, and intensity in this population has yet to be fully elucidated. Many cancer rehabilitation programmes presented in the literature are very long, have tight eligibility criteria and are not likely to be practical in the majority of cancer survivors. We plan to investigate a novel brief 8-week intervention which aims to increase physical fitness, and address other physical symptoms in a heterogeneous cancer survivor population.
Methods/design: Approximately 60 cancer survivors 2-6 months after completion of chemotherapy, usually adjuvant, with curative intent will be recruited through oncology clinics in a single institution and randomised to usual care or an exercise intervention. The exercise intervention consists of two specifically tailored, supervised, moderate intensity aerobic exercise sessions per week for 8 weeks. All participants will be assessed at baseline (0 weeks), post intervention (8 weeks), and at 3-month follow-up. The primary outcome measure is fitness, and secondary patient-related outcome measures include fatigue, quality of life, and morphological outcomes. A further secondary outcome is process evaluation including adherence to and compliance with the exercise program.
Discussion: This study will provide valuable information about the physical outcomes of this 8-week supervised aerobic programme. Additional process information and economic evaluation will inform the feasibility of implementing this program in a heterogeneous population after chemotherapy treatment with curative intent.
研究の種類
入学 (実際)
段階
- フェーズ 3
連絡先と場所
研究場所
-
-
-
Dublin、アイルランド、8
- Medical Oncology Department, St. James's Hospital
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Diagnosis of solid tumour and completion of adjuvant chemotherapy (and/or radiotherapy) with curative intent within the preceding 2-6 months. (Patients who have received neoadjuvant chemotherapy or chemoradiotherapy followed by surgery will also be eligible. In addition, patients continuing onto adjuvant hormone therapy and anti-Her2 directed therapy are eligible).
- Ability to understand English
- Willing to be randomised
- Medical clearance to exercise
- Age 21-69
- Fitness level average, fair or poor according to certain pre-determined cut-off points for age and gender(Fletcher et al., 2001)
- Willing and able to attend supervised exercise sessions twice weekly for a period of 8 weeks, with an intention of achieving > 90% attendance
- LVEF > 50% and not < 20% worse than baseline in applicable patients
Exclusion Criteria:
- Evidence of active cancer
- Chronic medical and orthopaedic conditions that would preclude exercise (eg uncontrolled congestive heart failure or angina, recent MI, breathing difficulties requiring oxygen use or hospitalization)
- On beta-blocker medication
- Prior history of another cancer in previous 5 years (exception: non-melanoma skin cancer and non-invasive cancer of the cervix)
- Confirmed pregnancy
- Dementia or psychiatric illness that would preclude ability to participate in study
- Incomplete haematological recovery after chemotherapy (WCC< 3, Hb < 10 or Platelets < 100)
- BMI > 35
- LVEF post chemotherapy < 50% or > 20% deterioration of baseline pre-systemic treatment. LVEF criteria are applicable in patients who have received chemotherapy deemed in normal clinical practice to have a potential effect LVEF and in whom the LVEF will have been measured before systemic treatment and at end of chemotherapy
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ：Exercise Programme
This will consist of an 8-week exercise programme, performed twice per week.
|
Moderate intensity exercise
|
|
プラセボコンパレーター：Usual Care
Standard practice including opportunistic exercise advice and patients' self-directed physical activity
|
Moderate intensity exercise
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
Modified Bruce Treadmill Test (Fitness)
時間枠：0, 8 weeks, 3 months
|
0, 8 weeks, 3 months
|
二次結果の測定
結果測定 |
時間枠 |
|---|---|
|
FACT-G scale (Quality of life-overall)
時間枠：0, 8 weeks, 3 months
|
0, 8 weeks, 3 months
|
|
FACT-F (Fatigue)
時間枠：0, 8 weeks, 3 months
|
0, 8 weeks, 3 months
|
|
RT3 Accelerometry (Activity level)
時間枠：0, 8 weeks, 3 months
|
0, 8 weeks, 3 months
|
|
Tanita Body Fat Assessment (% fat)
時間枠：0, 8 weeks, 3 months
|
0, 8 weeks, 3 months
|
|
SF-36v2 (Quality of life-functional aspects)
時間枠：0, 8 weeks and 3 months
|
0, 8 weeks and 3 months
|
協力者と研究者
捜査官
- 主任研究者：Dearbhaile O' Donnell, MD、St. James's Hospital, Dublin, Ireland
- 主任研究者：Juliette Hussey, PhD、Trinity College Dublin, Ireland
- 主任研究者：Julie M Walsh, MSc、University of Dublin, Trinity College
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。